tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alethia Young, 299 are a BUY (83.52%), 57 are a HOLD (15.92%), 2 are a SELL (0.56%).
Analyst Alethia Young, carries an average stock price target met ratio of 61.08% that have a potential upside of 46.75% achieved within 349 days. Previously, Alethia Young worked at CANTOR FITZGERALD, CREDIT SUISSE, DEUTSCHE BANK.
Alethia Young’s has documented 718 price targets and ratings displayed on 62 stocks. The coverage was on Healthcare, Basic Materials, Communication Services, Technology sectors.
Most recent stock forecast was given on STOK, Stoke Therapeutics at 08-Jan-2025.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for BIIB (BIOGEN) at 11/3/2020. The price target of $278 was fulfilled within 1 day with a profit of $30.99 (12.55%) receiving and performance score of 125.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Nov-2019
$11
6 years 11 months 24 days ago
(07-Nov-2019)
0/2 (0%)
$11 (0.00%)
$5
$4.82 (2677.78%)
$5
7 years 13 days ago
(18-Oct-2019)
0/4 (0%)
$5 (0.00%)
$2.5
$2.32 (1288.89%)
$8
7 years 5 months 28 days ago
(03-May-2019)
0/2 (0%)
$2.5 (0.00%)
$3.5
$3.32 (1844.44%)
$4
8 years 8 months 23 days ago
(08-Feb-2018)
0/4 (0%)
$3.5 (0.00%)
$650
$649.82 (361011.12%)
$16
9 years 1 months 19 days ago
(12-Sep-2017)
0/2 (0%)
$650 (0.00%)
